Matthew Coapman - CbdMD Chief Officer
| YCBD-PA Preferred Stock | USD 0.75 0.05 7.14% |
Insider
Matthew Coapman is Chief Officer of cbdMD Inc
| Age | 47 |
| Phone | 704 445 3060 |
| Web | https://www.cbdmd.com |
CbdMD Management Efficiency
The company has return on total asset (ROA) of (0.1306) % which means that it has lost $0.1306 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.0416) %, meaning that it generated substantial loss on money invested by shareholders. CbdMD's management efficiency ratios could be used to measure how well CbdMD manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Andrew Wiederhorn | FAT Brands | 57 | |
| Allen JD | FAT Brands | 58 | |
| Michael Chachula | FAT Brands | N/A | |
| Sibyl Swift | cbdMD Inc | 43 | |
| John Weston | cbdMD Inc | N/A | |
| CFA CFA | FAT Brands | 64 | |
| Robert Rosen | FAT Brands | 57 | |
| Michael Esq | Fortress Biotech Pref | 57 | |
| Kevin MacDermott | cbdMD Inc | 62 | |
| Ron Roe | FAT Brands | 46 | |
| Raymond Coffman | cbdMD Inc | 62 | |
| Thomas Schaible | Fortress Biotech Pref | N/A | |
| Samuel Berry | Fortress Biotech Pref | N/A | |
| Donald Berchtold | FAT Brands | 77 | |
| Kenneth Kuick | FAT Brands | 54 | |
| Thayer Wiederhorn | FAT Brands | 34 | |
| Gregg Nettleton | FAT Brands | 67 | |
| David Jin | Fortress Biotech Pref | 33 | |
Management Performance
| Return On Equity | -1.04 | ||||
| Return On Asset | -0.13 |
cbdMD Inc Leadership Team
Elected by the shareholders, the CbdMD's board of directors comprises two types of representatives: CbdMD inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CbdMD. The board's role is to monitor CbdMD's management team and ensure that shareholders' interests are well served. CbdMD's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CbdMD's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Matthew Coapman, Chief Officer | ||
| Raymond Coffman, CoFounder Chairman | ||
| Lance Blundell, G Counsel | ||
| Kevin MacDermott, President | ||
| John Weston, Director Relations | ||
| David Johnson, Sr Devel | ||
| Sibyl Swift, VP Affairs | ||
| Francisco Mangual, VP Sales | ||
| Robert Pettway, Director PR | ||
| Ronan Kennedy, COO, CFO |
CbdMD Preferred Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right preferred stock is not an easy task. Is CbdMD a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.04 | ||||
| Return On Asset | -0.13 | ||||
| Profit Margin | (1.98) % | ||||
| Operating Margin | (0.49) % | ||||
| Current Valuation | 350.88 M | ||||
| Shares Owned By Institutions | 9.69 % | ||||
| Revenue | 35.4 M | ||||
| Gross Profit | 22.34 M | ||||
| EBITDA | (70.06 M) | ||||
| Net Income | (70.08 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in CbdMD Preferred Stock
CbdMD financial ratios help investors to determine whether CbdMD Preferred Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CbdMD with respect to the benefits of owning CbdMD security.